From: BULLELKMAN@aol.com Sent: Tuesday, November 09, 2004 1:51 AM To: FDADockets@oc.fda.gov; brownchas@erols.com Cc: FreKoss@aol.com; sandyduffy@comcast.net Subject: Docket Number # 03N-0169 Dear FDA, Please post this e-mail to Docket Number # 03N-0169. It is imperative that this important information becomes part of public record on mercury dental fillings. By recording this e-mail to Docket Number #03N-0169, it becomes information that will be available to the "public" to include the American public, elected officials and the media because of Freedom of Information Act. It is critical that the "public" has access to this information. Thank you, Mary Ann Newell Manager of the Files for Consumers for Dental Choice *************************************************** Maritza E. Carpenter, CPA National Institutes of Health Office of the Director Division ofProgram Integrity Re: Case 2004-99: Investigation of Lawrence Tabak, Director ofNIDCR, et al., re Contractto do “Independent” Review of Science on Mercury Amalgam Dear CPA Carpenter: On October 26, replying to lettersreceived from both Director Zerhouni and Suzanne Servis (Director of the Officeof Management Assessment at NIH), we sent a second substantial submissionregarding the Tabak-Braveman deal with LSRO Inc. and BETAH Associates. In ourreport, we suggest 16 issues pertaining to contract irregularities by the verytop people at the National Institute of Dental and Craniofacial Research, partof a pattern to avoid independent review of mercury-based dental fillings – thusprotecting organized dentistry and withholding valuable information aboutmercury exposure to American families. As I understand you are in charge ofthis investigation, we mailed you a hard copy of that letter, along with morethan 20 exhibits. For your convenience,I am attaching an electronic version of the report and its cover letter. The exhibits are not attached, but we havescanned most or all of them, and can send them as well at your request. Sincerely, Charles G. Brown, nationalcounsel Consumersfor Dental Choice 1725 K St., N.W., Suite 511 Washington, DC 20006 Ph. 202.822-6307; fax822-6309 www,toxicteeth.org Nov. 4, 2004 cc--Kele Onyejekwe, Esq. Freya Koss, Director of Development,Consumers for Dental Choice